BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31087225)

  • 1. Risk of bleeding events among patients with systemic sclerosis and the general population in the UK: a large population-based cohort study.
    Michel A; González-Pérez A; Sáez ME; García Rodríguez LA
    Clin Rheumatol; 2020 Jan; 39(1):19-26. PubMed ID: 31087225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary epidemiology of systemic sclerosis: A population-based cohort study in the United Kingdom.
    García Rodríguez LA; González-Pérez A; Michel A; Sáez ME
    Semin Arthritis Rheum; 2019 Aug; 49(1):105-111. PubMed ID: 30470546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.
    Man A; Zhu Y; Zhang Y; Dubreuil M; Rho YH; Peloquin C; Simms RW; Choi HK
    Ann Rheum Dis; 2013 Jul; 72(7):1188-93. PubMed ID: 22904260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of gastrointestinal hemorrhage in patients with systemic sclerosis.
    Lin YT; Chuang YS; Wang JW; Wu PH
    Arthritis Res Ther; 2019 Dec; 21(1):301. PubMed ID: 31878956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink.
    Pauling JD; McGrogan A; Snowball J; McHugh NJ
    Rheumatology (Oxford); 2021 Jun; 60(6):2688-2696. PubMed ID: 33212504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.
    Schoenfeld SR; Choi HK; Sayre EC; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2016 Feb; 68(2):246-53. PubMed ID: 26212772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.
    Chung WS; Lin CL; Sung FC; Hsu WH; Yang WT; Lu CC; Kao CH
    Rheumatology (Oxford); 2014 Sep; 53(9):1639-45. PubMed ID: 24717920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study.
    Lai CC; Wang SH; Chen WS; Liu CJ; Chen TJ; Lee PC; Chang YS
    Ann Rheum Dis; 2015 Jul; 74(7):1347-52. PubMed ID: 24532679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study.
    Kwon OC; Han K; Park MC
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37945288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study.
    Butt SA; Jeppesen JL; Torp-Pedersen C; Sam F; Gislason GH; Jacobsen S; Andersson C
    J Am Heart Assoc; 2019 Sep; 8(17):e013405. PubMed ID: 31446827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study.
    Bairkdar M; Chen EY; Dickman PW; Hesselstrand R; Westerlind H; Holmqvist M
    Rheumatology (Oxford); 2023 Mar; 62(3):1170-1178. PubMed ID: 35984290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis is a risk factor of incident psoriasis: results from a nationwide cohort study.
    Kwon OC; Han K; Park MC
    Front Immunol; 2023; 14():1326298. PubMed ID: 38155970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
    Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of systemic sclerosis in a large US managed care population.
    Furst DE; Fernandes AW; Iorga SR; Greth W; Bancroft T
    J Rheumatol; 2012 Apr; 39(4):784-6. PubMed ID: 22382343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M; Bonner A; Hudson M; Baron M; Pope JE;
    Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Risk of Ischemic Stroke in Systemic Sclerosis: A National Cohort Study of US Veterans.
    Ying D; Gianfrancesco MA; Trupin L; Yazdany J; Greidinger EL; Schmajuk G
    J Rheumatol; 2020 Jan; 47(1):82-88. PubMed ID: 30877213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.
    Kuo CF; See LC; Yu KH; Chou IJ; Tseng WY; Chang HC; Shen YM; Luo SF
    Scand J Rheumatol; 2011; 40(5):373-8. PubMed ID: 21388247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study.
    Singh JA; Cleveland JD
    Clin Rheumatol; 2020 Jan; 39(1):85-92. PubMed ID: 31444650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding Risk of Warfarin and Direct Oral Anticoagulants in Younger Population: A Historical Cohort Study Using a Japanese Claims Database.
    Yokoyama S; Tanaka Y; Nakagita K; Hosomi K; Takada M
    Int J Med Sci; 2018; 15(14):1686-1693. PubMed ID: 30588192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.